Yale University: Obsessive-Compulsive Disorder trials

The registry lists 13 Obsessive-Compulsive Disorder studies with Yale University as lead sponsor. 3 are open to participants now and 5 have results posted.

Phase 1 3Phase 2 5No phase 6(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Aerobic Exercise and Obsessive-Compulsive Disorder SymptomsRecruitingNCT07103902Not applicable
• Transcranial Direct Current Stimulation and Extinction in Obsessive Compulsive DisorderRecruitingNCT06834217Not applicable
• Brain Network Changes Accompanying and Predicting Responses to Pharmacotherapy in OCDRecruitingNCT04131829Phase 1/2
• Efficacy of Psilocybin in OCD: a Double-Blind, Placebo-Controlled Study.CompletedNCT03356483Phase 1Results posted
• Ketamine Infusion for Obsessive-Compulsive DisorderCompletedNCT01349231Phase 2Results posted
• N-acetylcysteine (NAC) for Pediatric Obsessive-Compulsive DisorderCompletedNCT01172275Phase 2Results posted
• N-Acetylcysteine Augmentation in Treatment-Refractory Obsessive-Compulsive DisorderTerminatedNCT00539513Phase 2Results posted
• Riluzole Augmentation in Treatment-refractory Obsessive-compulsive DisorderCompletedNCT00523718Phase 2Results posted
• Computer Game, Qualitative, and MEG/EEG Assessment of Serotonergic PsychedelicsTerminatedNCT06624137
• Using Virtual Reality Before Transcranial Magnetic Stimulation for the Treatment of OCDWithdrawnNCT06442527Not applicable
• Effects of Repeated Psilocybin Dosing in OCDActive, not recruitingNCT05370911Phase 1
• Enhancement of Therapeutic Learning in OCD Using tDCSCompletedNCT03572543Not applicable
• Neurofeedback for Obsessive-Compulsive Disorder (OCD)CompletedNCT02206945Not applicable